Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 13 (1), R12-9
- https://doi.org/10.1186/cc7710
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008
- Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolismJournal of Neuroinflammation, 2008
- The Complement Anaphylatoxin C5a Induces Apoptosis in Adrenomedullary Cells during Experimental SepsisPLOS ONE, 2008
- Functional roles for C5a receptors in sepsisNature Medicine, 2008
- TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1Neurochemistry International, 2008
- An essential role for complement C5a in the pathogenesis of septic cardiac dysfunctionThe Journal of Experimental Medicine, 2005
- Septic shockThe Lancet, 2005
- C5a-induced expression of P-selectin in endothelial cells.JCI Insight, 1994
- Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐IClinical Endocrinology, 1991